Analysts Comment on Biogen-Idec (BIIB) and Genentech (DNA) Following Rituxan PML Death News
Go back to Analysts Comment on Biogen-Idec (BIIB) and Genentech (DNA) Following Rituxan PML Death News| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.99 +3.64 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.91 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 286,911 | |||||
| Genentech, Inc. (NYSE: DNA) | Delayed: 7.31 +0.35 (5.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.96 | 52 Week High | $99.14 | |||
| Open | $7.09 | 52 Week Low | $69.17 | |||
| Day High | $7.37 | P/E | 2.28 | |||
| Day Low | $6.82 | EPS | $3.21 | |||
| Volume | 685,278 | |||||
